risedronic acid has been researched along with Vasculitis in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Vasculitis: Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belhadjali, H | 1 |
| Slim, R | 1 |
| Aouam, K | 1 |
| Youssef, M | 1 |
| Zili, J | 1 |
1 other study available for risedronic acid and Vasculitis
| Article | Year |
|---|---|
Cutaneous vasculitis induced by risedronate.
Topics: Aged; Bone Density Conservation Agents; Etidronic Acid; Female; Humans; Risedronic Acid; Skin Diseas | 2008 |